BMO Capital Markets maintained its Outperform rating and $545.00 price target on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), representing a 16% upside from the current price of $469.97. With a ...

The vertex shader is used to transform the attributes of vertices (points of a triangle) such as color, texture, position and direction from the original color space to the display space.

In case you have any doubts about my opinion of Vertex, I think it is a biotech stock to buy hand over fist before Jan. 30. The company has a strong financial position thanks to its dominance in ...

GHP Investment Advisors Inc. bought a new position in shares of Vertex Pharmaceuticals during the second quarter valued at $29,000. HBK Sorce Advisory LLC bought a new position in shares of Vertex ...

This approval is tremendously important for Vertex Pharmaceuticals ... It hopes to be in a position to file for accelerated approval in the U.S. for the drug once an interim analysis cohort ...

Vertex Pharmaceuticals Stock Up 3.1 % Shares of NASDAQ VRTX opened at $424.26 on Thursday. Vertex Pharmaceuticals Incorporated has a 52-week low of $377.85 and a 52-week high of $519.88. The ...